Increased Lymphocyte Activation
- Name
- Increased Lymphocyte Activation
- Accession Number
- DBCAT004234
- Description
Not Available
- Drugs
Drug Drug Description Aldesleukin A recombinant analog of interleukin-2 used to induce an adaptive immune response in the treatment of renal cell carcinoma. - Drugs & Drug Targets